CYTOKINETICS INC (CYTK)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 60M 120M 180M Q4 '10: 2.6M Q1 '11: 2.7M Q2 '11: 3.3M Q3 '11: 4.3M Q4 '11: 4M Q1 '12: 5.1M Q2 '12: 5.8M Q3 '12: 6.1M Q4 '12: 7.6M Q1 '13: 6.6M Q2 '13: 5.7M Q3 '13: 8.5M Q4 '13: 30.6M Q1 '14: 37.8M Q2 '14: 44.6M Q3 '14: 49.5M Q4 '14: 46.9M Q1 '15: 43.4M Q2 '15: 42.1M Q3 '15: 40.7M Q4 '15: 28.7M Q1 '16: 32.7M Q2 '16: 31.9M Q3 '16: 83M Q4 '16: 106.4M Q1 '17: 102.1M Q2 '17: 99.4M Q3 '17: 46.5M Q4 '17: 13.4M Q1 '18: 14.5M Q2 '18: 17.6M Q3 '18: 22.1M Q4 '18: 31.5M Q1 '19: 34.7M Q2 '19: 35.6M Q3 '19: 31M Q4 '19: 26.9M Q1 '20: 22.2M Q2 '20: 18.7M Q3 '20: 54.3M Q4 '20: 55.8M Q1 '21: 58.6M Q2 '21: 57.8M Q3 '21: 21.6M Q4 '21: 70.4M Q1 '22: 65M Q2 '22: 151.2M Q3 '22: 148.2M Q4 '22: 94.6M Q1 '23: 98.1M Q2 '23: 10M Q3 '23: 7.8M Q4 '23: 7.5M Q1 '24: 3.8M Q2 '24: 3.1M Q3 '24: 3.2M Q4 '24: 18.5M Q1 '25: 19.2M Q2 '25: 85.7M Q3 '25: 87.2M Q4 '25: 88M Q1 '26: 105.8M Q2 '26: 67.7M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

-750M -500M -250M 0 250M 500M 750M Q4 '10: -49.6M Q1 '11: -49.1M Q2 '11: -49.6M Q3 '11: -47.7M Q4 '11: -48M Q1 '12: -46.2M Q2 '12: -41.5M Q3 '12: -40.9M Q4 '12: -40.5M Q1 '13: -43.2M Q2 '13: -49.3M Q3 '13: -51.8M Q4 '13: -33.9M Q1 '14: -30M Q2 '14: -23.4M Q3 '14: -16.7M Q4 '14: -14.8M Q1 '15: -14.9M Q2 '15: -17.1M Q3 '15: -20M Q4 '15: -37.4M Q1 '16: -40.5M Q2 '16: -40.9M Q3 '16: 2M Q4 '16: 18.7M Q1 '17: 7.4M Q2 '17: -6.8M Q3 '17: -69.2M Q4 '17: -113.4M Q1 '18: -116.3M Q2 '18: -114.5M Q3 '18: -104M Q4 '18: -88.9M Q1 '19: -87.3M Q2 '19: -90.6M Q3 '19: -96.6M Q4 '19: -98.9M Q1 '20: -104.7M Q2 '20: -110.4M Q3 '20: -81.2M Q4 '20: -93.9M Q1 '21: -104.2M Q2 '21: -126.6M Q3 '21: -201M Q4 '21: -186.3M Q1 '22: -223.6M Q2 '22: -179.6M Q3 '22: -218.9M Q4 '22: -324.2M Q1 '23: -370.8M Q2 '23: -482M Q3 '23: -495.8M Q4 '23: -496.2M Q1 '24: -498M Q2 '24: -506.1M Q3 '24: -524.6M Q4 '24: -536.2M Q1 '25: -565.6M Q2 '25: -547M Q3 '25: -572.9M Q4 '25: -612.3M Q1 '26: -640.2M Q2 '26: -707.9M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Net Income TTM

-1.1B -700M -350M 0 350M 700M 1.1B Q4 '10: -49.3M Q1 '11: -48.8M Q2 '11: -49.3M Q3 '11: -47.6M Q4 '11: -47.9M Q1 '12: -46.1M Q2 '12: -41.4M Q3 '12: -40.8M Q4 '12: -40.4M Q1 '13: -43.1M Q2 '13: -49.2M Q3 '13: -51.7M Q4 '13: -33.7M Q1 '14: -29.8M Q2 '14: -23.2M Q3 '14: -16.6M Q4 '14: -14.6M Q1 '15: -14.8M Q2 '15: -17M Q3 '15: -19.8M Q4 '15: -37.5M Q1 '16: -41.1M Q2 '16: -42.1M Q3 '16: 67K Q4 '16: 16.5M Q1 '17: 3M Q2 '17: -14.4M Q3 '17: -80.1M Q4 '17: -127.8M Q1 '18: -132.2M Q2 '18: -130.6M Q3 '18: -120.3M Q4 '18: -106.3M Q1 '19: -105.4M Q2 '19: -110M Q3 '19: -117.5M Q4 '19: -121.7M Q1 '20: -131.7M Q2 '20: -140.4M Q3 '20: -114M Q4 '20: -127.3M Q1 '21: -135M Q2 '21: -155.8M Q3 '21: -228.7M Q4 '21: -215.3M Q1 '22: -257.7M Q2 '22: -215.9M Q3 '22: -282.1M Q4 '22: -389M Q1 '23: -430.8M Q2 '23: -539.6M Q3 '23: -526.7M Q4 '23: -526.2M Q1 '24: -530.6M Q2 '24: -545.3M Q3 '24: -576.4M Q4 '24: -589.5M Q1 '25: -615.3M Q2 '25: -606.3M Q3 '25: -751.9M Q4 '25: -785M Q1 '26: -829.6M Q2 '26: -894M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

-600M -400M -200M 0 200M 400M 600M Q2 '11: -44.8M Q3 '11: -43.7M Q4 '11: -45.6M Q1 '12: -41.5M Q2 '12: -37.6M Q3 '12: -37.3M Q4 '12: -33.4M Q1 '13: -36.9M Q2 '13: -21.6M Q3 '13: -2.4M Q4 '13: -7.7M Q1 '14: -13.3M Q2 '14: -29.3M Q3 '14: -49.1M Q4 '14: -44.8M Q1 '15: 7.3M Q2 '15: 7.5M Q3 '15: 6.7M Q4 '15: 4.9M Q1 '16: -47M Q2 '16: -49M Q3 '16: -50.8M Q4 '17: -101.8M Q1 '18: -110.6M Q2 '18: -106.2M Q3 '18: -113M Q4 '18: -101.2M Q1 '19: -98.3M Q2 '19: -96.1M Q3 '19: -84.2M Q4 '19: -90.9M Q1 '20: -94.1M Q2 '20: -96.9M Q3 '20: -62.3M Q4 '20: 8.9M Q1 '21: 9.6M Q2 '21: 7.5M Q3 '21: -45.6M Q4 '21: -142.5M Q1 '22: -139.8M Q2 '22: -200.8M Q3 '22: -246.1M Q4 '22: -299.5M Q1 '23: -395M Q2 '23: -426.3M Q3 '23: -438.5M Q4 '23: -414.3M Q1 '24: -421.6M Q2 '24: -399.1M Q3 '24: -404.4M Q4 '24: -395.9M Q1 '25: -398M Q2 '25: -426.9M Q3 '25: -432.9M Q4 '25: -510M Q1 '26: -523.8M Q2 '26: -555.5M Q2 '11 Q2 '13 Q2 '15 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow TTM

-600M -400M -200M 0 200M 400M 600M Q2 '11: -45.3M Q3 '11: -44.2M Q4 '11: -46M Q1 '12: -41.7M Q2 '12: -37.8M Q3 '12: -37.4M Q4 '12: -33.6M Q1 '13: -37.2M Q2 '13: -21.9M Q3 '13: -2.8M Q4 '13: -8.3M Q1 '14: -14M Q2 '14: -30.4M Q3 '14: -50.3M Q4 '14: -45.9M Q1 '15: 6.4M Q2 '15: 6.9M Q3 '15: 6.1M Q4 '15: 4.3M Q1 '16: -47.8M Q2 '16: -49.7M Q3 '16: -51.7M Q4 '17: -104.6M Q1 '18: -112.4M Q2 '18: -107.8M Q3 '18: -114.4M Q4 '18: -102.1M Q1 '19: -99.2M Q2 '19: -97M Q3 '19: -85.7M Q4 '19: -93.5M Q1 '20: -97.5M Q2 '20: -101.1M Q3 '20: -68.1M Q4 '20: -2.1M Q1 '21: -7.1M Q2 '21: -17.1M Q3 '21: -83.3M Q4 '21: -191.4M Q1 '22: -183M Q2 '22: -236M Q3 '22: -271.9M Q4 '22: -310.9M Q1 '23: -405.8M Q2 '23: -437M Q3 '23: -443M Q4 '23: -415.7M Q1 '24: -422.6M Q2 '24: -401.3M Q3 '24: -407.1M Q4 '24: -399.8M Q1 '25: -407.6M Q2 '25: -438.7M Q3 '25: -453.4M Q4 '25: -534.8M Q1 '26: -548.9M Q2 '26: -580.7M Q2 '11 Q2 '13 Q2 '15 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q3 '15: 38.8M Q3 '16: 43.2M Q3 '17: 53.7M Q2 '21: 71.8K Q3 '21: 80.3K Q1 '22: 85K Q2 '22: 85.7K Q3 '22: 93.8K Q1 '23: 95.2K Q2 '23: 95.8K Q3 '23: 96.1K Q1 '24: 101.9K Q2 '24: 109.2K Q3 '24: 117.7K Q1 '25: 118.5K Q2 '25: 119.5K Q3 '25: 120K Q1 '26: 123.3K Q2 '26: 132.1K Q3 '15 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6.00 -4.00 -2.00 0.00 2.00 4.00 6.00 Q4 '10: -0.77 Q1 '11: -0.76 Q2 '11: -0.78 Q3 '11: -0.74 Q4 '11: -4.31 Q1 '12: -4.26 Q2 '12: -4.79 Q3 '12: -5.09 Q4 '12: -1.78 Q1 '13: -2.18 Q2 '13: -2.00 Q3 '13: -1.98 Q4 '13: -1.24 Q1 '14: -0.98 Q2 '14: -0.63 Q3 '14: -0.36 Q4 '14: -0.41 Q1 '15: -0.37 Q2 '15: -0.41 Q3 '15: -0.48 Q4 '15: -0.97 Q1 '16: -1.05 Q2 '16: -1.07 Q3 '16: -0.07 Q4 '16: 0.33 Q1 '17: 0.02 Q2 '17: -0.29 Q3 '17: -1.66 Q4 '17: -2.59 Q1 '18: -2.53 Q2 '18: -2.44 Q3 '18: -2.24 Q4 '18: -1.95 Q1 '19: -1.93 Q2 '19: -1.98 Q3 '19: -2.08 Q4 '19: -2.11 Q1 '20: -2.23 Q2 '20: -2.35 Q3 '20: -1.90 Q4 '20: -2.02 Q1 '21: -2.02 Q1 '12 Q3 '13 Q1 '15 Q3 '16 Q1 '18 Q3 '19 Q1 '21

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.